CoChat

Cations as Switches of Amyloid-Mediated Membrane Disruption Mechanisms: Calcium and IAPP

Sciacca, Michele F.M., Milardi, Danilo, Messina, Grazia M.L., Marletta, Giovanni, Brender, Jeffrey R., Ramamoorthy, Ayyalusamy, La Rosa, Carmelo · 2013 · Biophysical Journal
Cited by 111

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bpj.2012.11.3811

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 83

  1. Sipe, 2000, Review: history of the amyloid fibril, J. Struct. Biol., 130, 88, 10.1006/jsbi.2000.4221 · DOI · Paper page
  2. Moore, 1991, Co-secretion of amylin and insulin from cultured islet β-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents, Biochem. Biophys. Res. Commun., 179, 1, 10.1016/0006-291X(91)91325-7 · DOI
  3. Clark, 1987, Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes, Lancet, 2, 231, 10.1016/S0140-6736(87)90825-7 · DOI · Paper page
  4. Westermark, 1987, Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals, Diabetologia, 30, 887, 10.1007/BF00274799 · DOI · Paper page
  5. Betsholtz, 1989, Islet amyloid polypeptide (IAPP):cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus, Exp. Cell Res., 183, 484, 10.1016/0014-4827(89)90407-2 · DOI
  6. Higham, 2000, Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils, FEBS Lett., 470, 55, 10.1016/S0014-5793(00)01287-4 · DOI
  7. Lorenzo, 1994, Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus, Nature, 368, 756, 10.1038/368756a0 · DOI · Paper page
  8. Mirzabekov, 1996, Pore formation by the cytotoxic islet amyloid peptide amylin, J. Biol. Chem., 271, 1988, 10.1074/jbc.271.4.1988 · DOI · Paper page
  9. Haataja, 2008, Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis, Endocr. Rev., 29, 303, 10.1210/er.2007-0037 · DOI · Paper page
  10. Moriarty, 1999, Effects of sequential proline substitutions on amyloid formation by human amylin20-29, Biochemistry, 38, 1811, 10.1021/bi981658g · DOI · Paper page
  11. Anguiano, 2002, Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes, Biochemistry, 41, 11338, 10.1021/bi020314u · DOI · Paper page
  12. Smith, 2009, Induction of negative curvature as a mechanism of cell toxicity by amyloidogenic peptides: the case of islet amyloid polypeptide, J. Am. Chem. Soc., 131, 4470, 10.1021/ja809002a · DOI
  13. Brender, 2012, Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective, Acc. Chem. Res., 45, 454, 10.1021/ar200189b · DOI · Paper page
  14. Hebda, 2009, The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights from type II diabetes, Annu Rev Biophys, 38, 125, 10.1146/annurev.biophys.050708.133622 · DOI · Paper page
  15. Last, 2011, Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity, Proc. Natl. Acad. Sci. USA, 108, 9460, 10.1073/pnas.1102356108 · DOI
  16. Lashuel, 2006, Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?, Q. Rev. Biophys., 39, 167, 10.1017/S0033583506004422 · DOI · Paper page
  17. Scalisi, 2010, Self-assembling pathway of HiApp fibrils within lipid bilayers, ChemBioChem, 11, 1856, 10.1002/cbic.201000090 · DOI
  18. Sparr, 2004, Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers, FEBS Lett., 577, 117, 10.1016/j.febslet.2004.09.075 · DOI · Paper page
  19. Engel, 2008, Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane, Proc. Natl. Acad. Sci. USA, 105, 6033, 10.1073/pnas.0708354105 · DOI · Paper page
  20. Green, 2004, Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide, J. Mol. Biol., 342, 877, 10.1016/j.jmb.2004.07.052 · DOI · Paper page
  21. Brender, 2011, Biphasic effects of insulin on islet amyloid polypeptide membrane disruption, Biophys. J., 100, 685, 10.1016/j.bpj.2010.09.070 · DOI
  22. Jayasinghe, 2005, Lipid membranes modulate the structure of islet amyloid polypeptide, Biochemistry, 44, 12113, 10.1021/bi050840w · DOI · Paper page
  23. Gehman, 2008, Metal effects on the membrane interactions of amyloid-β peptides, Eur. Biophys. J., 37, 333, 10.1007/s00249-007-0251-2 · DOI
  24. Fraser, 1997, Ionic effects of the Alzheimer’s disease β-amyloid precursor protein and its metabolic fragments, Trends Neurosci., 20, 67, 10.1016/S0166-2236(96)10079-5 · DOI
  25. Mattson, 1992, β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J. Neurosci., 12, 376, 10.1523/JNEUROSCI.12-02-00376.1992 · DOI · Paper page
  26. Kawahara, 2000, Alzheimer’s β-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line, J. Biol. Chem., 275, 14077, 10.1074/jbc.275.19.14077 · DOI · Paper page
  27. Resnick, 1992, Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders, Am. J. Med., 93, 11S, 10.1016/0002-9343(92)90290-R · DOI
  28. Barbagallo, 1996, Cellular ions in NIDDM: relation of calcium to hyperglycemia and cardiac mass, Diabetes Care, 19, 1393, 10.2337/diacare.19.12.1393 · DOI
  29. Squier, 2000, Protein oxidation and age-dependent alterations in calcium homeostasis, Front. Biosci., 5, D504, 10.2741/Squier · DOI · Paper page
  30. Nitahara, 1998, Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats, J. Mol. Cell. Cardiol., 30, 519, 10.1006/jmcc.1997.0616 · DOI
  31. Gerke, 2005, Annexins: linking Ca2+ signalling to membrane dynamics, Nat. Rev. Mol. Cell Biol., 6, 449, 10.1038/nrm1661 · DOI · Paper page
  32. Rescher, 2004, Annexins—unique membrane binding proteins with diverse functions, J. Cell Sci., 117, 2631, 10.1242/jcs.01245 · DOI · Paper page
  33. Sciacca, 2008, Calcium-activated membrane interaction of the islet amyloid polypeptide: implications in the pathogenesis of type II diabetes mellitus, Arch. Biochem. Biophys., 477, 291, 10.1016/j.abb.2008.06.018 · DOI
  34. Grasso, 2005, Environmental effects on a prion’s helix II domain: copper(II) and membrane interactions with PrP180-193 and its analogues, Chemistry, 12, 537, 10.1002/chem.200500534 · doi:10.1002/chem.200500534
  35. Grasso, 2001, DSC study of the interaction of the prion peptide PrP106–126 with artificial membranes, New J. Chem., 25, 1543, 10.1039/b106227c · DOI
  36. Milardi, 2011, The role of aromatic side-chains in amyloid growth and membrane interaction of the islet amyloid polypeptide fragment LANFLVH, Eur. Biophys. J., 40, 1, 10.1007/s00249-010-0623-x · DOI
  37. Stewart, 1980, Colorimetric determination of phospholipids with ammonium ferrothiocyanate, Anal. Biochem., 104, 10, 10.1016/0003-2697(80)90269-9 · DOI · Paper page
  38. Merchant, 1992, 31P NMR of tissue phospholipids: competition for Mg2+, Ca2+, Na+ and K+ cations, Lipids, 27, 551, 10.1007/BF02536139 · doi:10.1007/bf02536139
  39. Nanga, 2011, Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment, Biochim. Biophys. Acta, 1808, 2337, 10.1016/j.bbamem.2011.06.012 · DOI · Paper page
  40. Schanda, 2007, Protein folding and unfolding studied at atomic resolution by fast two-dimensional NMR spectroscopy, Proc. Natl. Acad. Sci. USA, 104, 11257, 10.1073/pnas.0702069104 · DOI
  41. Roux, 1991, Calcium binding by phosphatidylserine headgroups. Deuterium NMR study, Biophys. J., 60, 38, 10.1016/S0006-3495(91)82028-8 · doi:10.1016/s0006-3495(91)82028-8
  42. Boettcher, 2011, Atomic view of calcium-induced clustering of phosphatidylserine in mixed lipid bilayers, Biochemistry, 50, 2264, 10.1021/bi1013694 · DOI
  43. Vernier, 2009, Calcium binding and head group dipole angle in phosphatidylserine-phosphatidylcholine bilayers, Langmuir, 25, 1020, 10.1021/la8025057 · DOI
  44. Knight, 2004, Phospholipid catalysis of diabetic amyloid assembly, J. Mol. Biol., 341, 1175, 10.1016/j.jmb.2004.06.086 · DOI · Paper page
  45. Düzgüneş, 1981, Calcium-induced and magnesium-induced fusion of mixed phosphatidylserine-phosphatidylcholine vesicles—effect of ion binding, J. Membrane Biol., 59, 115, 10.1007/BF01875709 · DOI
  46. McLaughlin, 1981, Adsorption of divalent cations to bilayer membranes containing phosphatidylserine, J. Gen. Physiol., 77, 445, 10.1085/jgp.77.4.445 · DOI · Paper page
  47. Martín-Molina, 2012, Effect of calcium and magnesium on phosphatidylserine membranes: experiments and all-atomic simulations, Biophys. J., 102, 2095, 10.1016/j.bpj.2012.03.009 · doi:10.1016/j.bpj.2012.03.009
  48. Jan, 2011, Aβ42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Aβ42 species, J. Biol. Chem., 286, 8585, 10.1074/jbc.M110.172411 · DOI · Paper page
  49. Brender, 2007, Membrane fragmentation by an amyloidogenic fragment of human islet amyloid polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes, Biochim. Biophys. Acta, 1768, 2026, 10.1016/j.bbamem.2007.07.001 · DOI
  50. Sasahara, 2012, Binding of islet amyloid polypeptide to supported lipid bilayers and amyloid aggregation at the membranes, Biochemistry, 51, 6908, 10.1021/bi300542g · DOI
  51. Sciacca, 2012, Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation, Biochemistry, 51, 7676, 10.1021/bi3009888 · DOI
  52. Sciacca, 2012, Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation, Biophys. J., 103, 702, 10.1016/j.bpj.2012.06.045 · DOI · Paper page
  53. Sauerbrey, 1959, Verwendung von schwingquarzen zur wagung dunner schichten und zur mikrowagung, Z. Phys., 155, 206
  54. Feiler, 2007, Adsorption and viscoelastic properties of fractionated mucin (BSM) and bovine serum albumin (BSA) studied with quartz crystal microbalance (QCM-D), J. Colloid Interface Sci., 315, 475, 10.1016/j.jcis.2007.07.029 · DOI · Paper page
  55. Richter, 2003, Pathways of lipid vesicle deposition on solid surfaces: a combined QCM-D and AFM study, Biophys. J., 85, 3035, 10.1016/S0006-3495(03)74722-5 · DOI · Paper page
  56. Sasahara, 2010, Effect of lipid type on the binding of lipid vesicles to islet amyloid polypeptide amyloid fibrils, Biochemistry, 49, 3040, 10.1021/bi9019252 · DOI
  57. Brender, 2008, A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity, Biochemistry, 47, 12680, 10.1021/bi801427c · DOI
  58. Glabe, 2006, Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis, Neurology, 66, S74
  59. Janson, 1999, The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles, Diabetes, 48, 491, 10.2337/diabetes.48.3.491 · DOI · Paper page
  60. Lashuel, 2002, Neurodegenerative disease: amyloid pores from pathogenic mutations, Nature, 418, 291, 10.1038/418291a · DOI · Paper page
  61. Wahlgren, 1995, The adsorption of lysozyme to hydrophilic silicon-oxide surfaces—comparison between experimental data and models for adsorption kinetics, J. Colloid Interface Sci., 175, 506, 10.1006/jcis.1995.1482 · doi:10.1006/jcis.1995.1482
  62. Patil, 2009, Dynamic α-helix structure of micelle-bound human amylin, J. Biol. Chem., 284, 11982, 10.1074/jbc.M809085200 · DOI · Paper page
  63. Balali-Mood, 2005, Neutron diffraction reveals sequence-specific membrane insertion of pre-fibrillar islet amyloid polypeptide and inhibition by rifampicin, FEBS Lett., 579, 1143, 10.1016/j.febslet.2004.12.085 · DOI
  64. Porat, 2003, The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies, Biochemistry, 42, 10971, 10.1021/bi034889i · DOI · Paper page
  65. Parkash, 2002, Intracellular calcium ion response to glucose in β-cells of calbindin-D28k nullmutant mice and in βHC13 cells overexpressing calbindin-D28k, Endocrine, 18, 221, 10.1385/ENDO:18:3:221 · DOI
  66. Taheri-Araghi, 2010, Electrostatic bending of lipid membranes: how are lipid and electrostatic properties interrelated?, Langmuir, 26, 14737, 10.1021/la102052r · doi:10.1021/la102052r
  67. Calloni, 2008, Structure and dynamics of a partially folded protein are decoupled from its mechanism of aggregation, J. Am. Chem. Soc., 130, 13040, 10.1021/ja8029224 · DOI
  68. Huang, 2010, Calcium-activated calpain-2 is a mediator of β cell dysfunction and apoptosis in type 2 diabetes, J. Biol. Chem., 285, 339, 10.1074/jbc.M109.024190 · DOI
  69. Brender, 2010, Role of zinc in human islet amyloid polypeptide aggregation, J. Am. Chem. Soc., 132, 8973, 10.1021/ja1007867 · DOI · Paper page
  70. Hall, 1982, Calcium-induced inactivation of alamethicin in asymmetric lipid bilayers, J. Gen. Physiol., 79, 387, 10.1085/jgp.79.3.387 · doi:10.1085/jgp.79.3.387
  71. Gambale, 1987, Effects of calcium on the gramicidin A single channel in phosphatidylserine membranes. Screening and blocking, Eur. Biophys. J., 14, 369, 10.1007/BF00262322 · DOI
  72. Meratan, 2011, Membrane integrity and amyloid cytotoxicity: a model study involving mitochondria and lysozyme fibrillation products, J. Mol. Biol., 409, 826, 10.1016/j.jmb.2011.04.045 · DOI
  73. Zakharov, 2007, Helical α-synuclein forms highly conductive ion channels, Biochemistry, 46, 14369, 10.1021/bi701275p · DOI
  74. Quist, 2005, Amyloid ion channels: a common structural link for protein-misfolding disease, Proc. Natl. Acad. Sci. USA, 102, 10427, 10.1073/pnas.0502066102 · DOI · Paper page
  75. Kagan, 2010, Amyloid peptide pores and the β sheet conformation, Adv. Exp. Med. Biol., 677, 150, 10.1007/978-1-4419-6327-7_13 · DOI
  76. Kagan, 2012, Antimicrobial properties of amyloid peptides, Mol. Pharm., 9, 708, 10.1021/mp200419b · DOI · Paper page
  77. Hirakura, 1999, Amyloid peptide channels are inhibited by Congo Red and blocked by zinc, Biophys. J., 76
  78. Bechinger, 2006, Detergent-like actions of linear amphipathic cationic antimicrobial peptides, Biochim. Biophys. Acta, 1758, 1529, 10.1016/j.bbamem.2006.07.001 · DOI · Paper page
  79. Nakazawa, 2009, The interaction of amyloid Aβ (1-40) with lipid bilayers and ganglioside as studied by 31P solid-state NMR, Chem. Phys. Lipids, 158, 54, 10.1016/j.chemphyslip.2008.12.001 · DOI
  80. Michikawa, 2001, A novel action of alzheimer’s amyloid β-protein (Aβ): oligomeric Aβ promotes lipid release, J. Neurosci., 21, 7226, 10.1523/JNEUROSCI.21-18-07226.2001 · DOI · Paper page
  81. Reynolds, 2011, Mechanism of membrane interaction and disruption by α-synuclein, J. Am. Chem. Soc., 133, 19366, 10.1021/ja2029848 · DOI · Paper page
  82. van Rooijen, 2010, Membrane interactions of oligomeric α-synuclein: potential role in Parkinson’s disease, Curr. Protein Pept. Sci., 11, 334, 10.2174/138920310791330659 · DOI
  83. Mattson, 2003, Calcium orchestrates apoptosis, Nat. Cell Biol., 5, 1041, 10.1038/ncb1203-1041 · DOI · Paper page

Cited by

See all 111

Metadata

Authors
Sciacca, M. F. M., Milardi, D., Messina, G. M. L., Marletta, G., Brender, J. R., Ramamoorthy, A., & La Rosa, C.
Venue
Biophysical Journal
Publisher
Elsevier BV
Published
2013-01
Volume
104
Issue
1
Pages
173-184
ISSN
0006-3495
Cited by
111
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.